1. 83.1% of patients with confirmed colorectal cancer had a positive cfDNA test meeting the accepted standard as outlined by the Food and Drug Administration. 2. Of patients without colorectal cancer, the majority (89.6%) tested negative in the screening blood test, meeting acceptable cut-offs for specificity. Evidence Rating Level: 2 (Good) Study Rundown: Colorectal cancer